Alison Frances Lawton
CIK 1542650 · See Remarks · last filed 2026-05-22
Alison Frances Lawton is a corporate insider who has filed 38 SEC Form 4 insider transactions across 10 companies since 2012. The most recent filing, for DNTH, was dated May 22, 2026. Across all open-market trades the lifetime net is +$22.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $396.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$396.9K
10
38
$22.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DNTH | Director | — | $82.07 | — | $0 | 4 | 2026-05-22 |
| XFOR | Director | 96,667 | $4.00 | $386.7K | $0 | 5 | 2024-06-11 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 4 | 2023-06-30 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Director | — | $11.19 | — | $0 | 3 | 2022-06-30 |
| Kaleido Biosciences, Inc. (KLDO) Delisted | See Remarks | — | $0.29 | — | $0 | 4 | 2020-04-17 |
| VSTM | Director | 2,500 | $4.10 | $10.2K | $22.9K | 7 | 2019-06-25 |
| CoLucid Pharmaceuticals, Inc. (CLCD) Delisted | Director | — | — | — | $0 | 4 | 2017-03-01 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Director | 0 | — | — | $0 | 1 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | Director | 2,714 | — | — | $0 | 4 | 2013-06-14 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Chief Operating Officer | — | — | — | $0 | 1 | 2013-06-11 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | XFOR | Grant (A) | +45,000 | $0 | EDGAR |
| 2024-05-28 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2023-09-13 | DNTH | Grant (A) | — | $0 | EDGAR |
| 2023-06-30 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-14 | XFOR | Grant (A) | +45,000 | $0 | EDGAR |
| 2022-06-30 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | XFOR | Grant (A) | +6,667 | $0 | EDGAR |
| 2022-06-10 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |